Page last updated: 2024-10-25

chlorpropamide and Endocrine System Diseases

chlorpropamide has been researched along with Endocrine System Diseases in 1 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Endocrine System Diseases: Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HAMWI, GJ1
SKILLMAN, TG1
KRUGER, FA1
FREEDY, LR1

Other Studies

1 other study available for chlorpropamide and Endocrine System Diseases

ArticleYear
The effects of chlorpropamide on endocrine function in patients with diabetes mellitus and its effects in other endocrine disorders.
    Annals of the New York Academy of Sciences, 1959, Mar-30, Volume: 74, Issue:3

    Topics: Chlorpropamide; Diabetes Mellitus; Endocrine System Diseases; Humans; Hypoglycemic Agents

1959